MAMMOTH BIOSCIENCES
Mammoth Biosciences is harnessing the diversity of nature to power the next-generation of CRISPR products. Through the discovery and development of novel CRISPR systems, the company is enabling the full potential of its platform to read and write the code of life. Mammoth Biosciences aims to democratize disease detection with an easy and affordable point-of-care test that allows real-time and simultaneous detection of multiple conditions. By leveraging its internal research and development and ... exclusive licensing to Cas12, Cas13, and Cas14, Mammoth Biosciences can provide enhanced diagnostics and genome editing for life science research, healthcare, agriculture, biodefense and more. Based in South San Francisco, Mammoth Biosciences is co-founded by CRISPR pioneer Jennifer Doudna and principal founders Trevor Martin, Janice Chen, and Lucas Harrington. The firm is backed by top institutional investors including Mayfield, NFX, and 8VC, Decheng Capital and leading individual investors including Brook Byers, Tim Cook, and Jeff Huber. Mammoth has also been working on developing a rapid COVID-19 test.
MAMMOTH BIOSCIENCES
Industry:
Biotechnology Genetics Health Diagnostics Life Science
Founded:
2017-01-01
Address:
San Francisco, California, United States
Country:
United States
Website Url:
http://www.mammoth.bio
Total Employee:
101+
Status:
Active
Contact:
+1-650-294-8583
Email Addresses:
[email protected]
Total Funding:
264.55 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SSL By Default Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress Google Universal Analytics Wordpress Plugins
Similar Organizations
Excision BioTherapeutics
Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Bradley Horowitz
Bradley Horowitz investment in Series D - Mammoth Biosciences
Plum Alley Investments
Plum Alley Investments investment in Series D - Mammoth Biosciences
Decheng Capital
Decheng Capital investment in Series D - Mammoth Biosciences
Senator Investment Group
Senator Investment Group investment in Series D - Mammoth Biosciences
Redmile Group
Redmile Group investment in Series D - Mammoth Biosciences
Sixth Street
Sixth Street investment in Series D - Mammoth Biosciences
Foresite Capital
Foresite Capital investment in Series D - Mammoth Biosciences
NFX
NFX investment in Series D - Mammoth Biosciences
Tachyon Ventures
Tachyon Ventures investment in Series D - Mammoth Biosciences
Mayfield Fund
Mayfield Fund investment in Series D - Mammoth Biosciences
Official Site Inspections
http://www.mammoth.bio Semrush global rank: 2.3 M Semrush visits lastest month: 8.15 K
- Host name: 151.101.194.159
- IP address: 151.101.194.159
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Mammoth Biosciences"
Mammoth Biosciences
Developing in vivo gene editing therapeutics to transform patient lives. Leveraging novel CRISPR-Cas enzymes and innovative technologies from our protein discovery and engineering platform.See details»
About Us - Mammoth Biosciences
Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop potential long-term curative therapies for patients with life-threatening and debilitating diseases.See details»
Company - Mammoth Biosciences
Publications. Learn more about our technology. Newsroom. Keep up with our latest newsSee details»
Mammoth Biosciences - Wikipedia
Mammoth Biosciences is a biotechnology company based in Brisbane, California developing diagnostic tests using CRISPR-Cas12a and CRISPR-based therapies using its proprietary ultra-small CRISPR systems. Several CRISPR-Cas systems identified through the company's metagenomics-based protein discovery platform, including members of the Casฯ and Cas14 families of CRISPR-associated enzymes, have demonstrated potential for therapeutic genome editingSee details»
Org Chart Mammoth Biosciences - The Official Board
The organizational chart of Mammoth Biosciences displays its 15 main executives including Trevor Martin, Elaine Sun and Janice ChenSee details»
Mammoth Biosciences - Crunchbase Company Profile โฆ
By leveraging its internal research and development and exclusive licensing to Cas12, Cas13, and Cas14, Mammoth Biosciences can provide enhanced diagnostics and genome editing for life science research, healthcare, โฆSee details»
Mammoth Biosciences - LinkedIn
Improving lives by reading and writing the code of life. Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop long-term...See details»
Mammoth Biosciences Raises $195 Million, Vaulting Its โฆ
Sep 9, 2021ย ยท On Thursday, Mammoth announced the company raised $195 million of financing at a valuation of more than $1 billion. The funding includes a $150 million Series D led by Redmile Group and a $45...See details»
Mammoth Biosciences Raises $195 Million to Build โฆ
Sep 9, 2021ย ยท The funds will enable the company to broaden its toolkit of next-generation CRISPR systems with a focus on building permanent genetic cures through in vivo gene-editing therapeutics and...See details»
Therapeutics - Mammoth Biosciences
Leveraging novel CRISPR-Cas enzymes and innovative technologies from our discovery and engineering platform. The small sizes of our NanoCas and CasPhi nucleases overcome the limitations of viral and non viral delivery that โฆSee details»
Amazon-backed biotech Mammoth raises $200m for โฆ
Sep 9, 2021ย ยท Mammoth Biosciences, the biotech co-founded by Nobel Prize winner Jennifer Doudna and that counts Amazon as a backer, has raised almost $200m to expand its use of novel Crispr-associated proteins...See details»
Vertex and Mammoth Biosciences Announce Collaboration to โฆ
Oct 26, 2021ย ยท BRISBANE, Calif.-- ( BUSINESS WIRE )--Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and Mammoth Biosciences, a biotech company building the next generation โฆSee details»
Regeneron and Mammoth Biosciences Collaborate to Pursue Next โฆ
Apr 25, 2024ย ยท TARRYTOWN, N.Y. and BRISBANE, Calif., April 25, 2024 โ Regeneron Pharmaceuticals, Inc. (NASDAQ: REGN) and Mammoth Biosciences, Inc., today announced a โฆSee details»
Mammoth Bio scores $195M top-up to supercharge CRISPR โฆ
Sep 9, 2021ย ยท On the back of a busy year, Mammoth Biosciences is getting a $195 million boost, which will ramp up the development of its gene-editing pipeline, as well as fuel its work in โฆSee details»
Partner - Mammoth Biosciences
Mammoth Biosciences is a biotechnology company focused on leveraging its proprietary ultracompact CRISPR systems to develop potential long-term curative therapies for patients โฆSee details»
MMB
? Specialization in Medical and Biological Image Data Post-Processing ? Innovative Software Tools and Technologies. ? Tailored Solutions for Clinical and Pre-Clinical Research Projects.See details»
Diagnostics - Mammoth Biosciences
DETECTRยฎ searches for the presence of specific nucleic acids in a sample that are indicative of disease, providing actionable clinical information. Our proprietary testing system works by โฆSee details»
Blog - Mammoth Biosciences
Mammoth Interviews: Joanne Kamens, PhD โ Creating a more inclusive science workplace Learn MoreSee details»
Publications Archive - Mammoth Biosciences
Deciphering Off-Target Effects in CRISPR-Cas9 through Accelerated Molecular Dynamics. A Functional Mini-Integrase in a Two-Protein-type V-C CRISPR System. Programmed DNA โฆSee details»
COVID-19 Resources - Mammoth Biosciences
Feb 25, 2020ย ยท Resources providing a general overview of the COVID-19 outbreak. Before you get into the nitty gritty of COVID-19, itโs good to get a broad overview of the disease and how it โฆSee details»